XML 125 R98.htm IDEA: XBRL DOCUMENT v3.23.1
Subsequent events (Details)
1 Months Ended 12 Months Ended
Mar. 31, 2023
USD ($)
$ / shares
shares
Mar. 23, 2023
USD ($)
$ / shares
shares
Mar. 20, 2023
USD ($)
Mar. 06, 2023
Center
Jul. 14, 2022
USD ($)
$ / shares
Jun. 14, 2021
USD ($)
$ / shares
shares
Mar. 31, 2023
USD ($)
director
item
$ / shares
shares
Feb. 28, 2023
USD ($)
item
Dec. 31, 2022
USD ($)
shares
Dec. 31, 2021
USD ($)
shares
Dec. 31, 2020
USD ($)
shares
Disclosure of non-adjusting events after reporting period [line items]                      
Aggregate amount received                 $ 55,000,000    
Warrants issued | shares                 0 0 0
Aggregate gross proceeds                   $ 35,107,872 $ 9,943,886
Private placement | Common Shares                      
Disclosure of non-adjusting events after reporting period [line items]                      
Issuance of common shares (in shares) | shares           2,353,347       2,353,347  
Price per share | $ / shares           $ 10.00          
Aggregate gross proceeds           $ 23,533,470          
Madryn Credit Facility                      
Disclosure of non-adjusting events after reporting period [line items]                      
Aggregate amount received         $ 55,000,000            
Amount of loan         55,000,000            
Spread on variable rate (in percent)                 9.00%    
Maximum outstanding principal amount to be converted         $ 5,000,000            
Conversion price | $ / shares         $ 1.90            
Restructuring Plan                      
Disclosure of non-adjusting events after reporting period [line items]                      
Number of TMS Centers to be closed | Center       50              
Number of remaining TMS Centers | Center       133              
Subsequent Debt Financing                      
Disclosure of non-adjusting events after reporting period [line items]                      
Aggregate amount received     $ 7,750,000                
Warrants issued | shares             135,870        
Number of shares each warrant converts into | shares 1           1        
Exercise price of warrant | $ / shares $ 1.84           $ 1.84        
Warrant expiration period (in years)             5 years        
Subsequent Debt Financing | Madryn                      
Disclosure of non-adjusting events after reporting period [line items]                      
Number of observers can be appointed | director             1        
Subsequent Debt Financing | Madryn Credit Facility                      
Disclosure of non-adjusting events after reporting period [line items]                      
Number of amendments to credit facility | item             4 4      
Number of additional tranches to debt financing | item             4 4      
Amount of loan $ 6,000,000           $ 6,000,000 $ 6,000,000      
Maximum outstanding principal amount to be converted $ 546,000           $ 546,000        
Conversion price | $ / shares $ 1.90           $ 1.90        
Subsequent Debt Financing | Madryn Credit Facility | LIBOR                      
Disclosure of non-adjusting events after reporting period [line items]                      
Spread on variable rate (in percent) 9.00%           9.00%        
Subsequent Debt Financing | Madryn Credit Facility | SOFR                      
Disclosure of non-adjusting events after reporting period [line items]                      
Spread on variable rate (in percent) 0.10%           0.10%        
Subsequent Debt Financing | Unsecured notes                      
Disclosure of non-adjusting events after reporting period [line items]                      
Aggregate amount received             $ 1,750,000        
Maximum outstanding principal amount to be converted $ 1,000,000.0           $ 1,000,000.0        
Percentage of conversion price on volume-weighted average trading price             85.00%        
Threshold period of volume weighted average trading price (in days)             5 days        
Private Placement of Common Shares | Private placement | Common Shares                      
Disclosure of non-adjusting events after reporting period [line items]                      
Issuance of common shares (in shares) | shares   11,363,635                  
Price per share | $ / shares   $ 0.55                  
Aggregate gross proceeds   $ 6,250,000                  
TMS Device Supply Arrangement with Neuronetics                      
Disclosure of non-adjusting events after reporting period [line items]                      
Account balance payables $ 5,700,000           $ 5,700,000        
Percentage of unpaid balance to be issued as common purchase share warrants in the event of default 200.00%                    
Discount rate on VWAP for exercise price 20.00%                    
VWAP period 30 days                    
TMS Device Supply Arrangement with Neuronetics | Neuronotics note                      
Disclosure of non-adjusting events after reporting period [line items]                      
Accounts payable converted to debt $ 6,000,000.0                    
TMS Device Supply Arrangement with Neuronetics | Neuronotics note | SOFR                      
Disclosure of non-adjusting events after reporting period [line items]                      
Spread on variable rate (in percent) 7.65%           7.65%